Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy (Q68289938)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

title

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

G. K. Rivera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

S. C. Raimondi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

M. L. Hancock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

F. G. Behm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

C. H. Pui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

M. Abromowitch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

J. Mirro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

J. S. Ochs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

A. T. Look

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

D. L. Williams

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1670723

25 October 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

12 January 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1670723

full work available at URL

25 October 2022

https://api.elsevier.com/content/article/PII:0140673691907336?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

https://api.elsevier.com/content/article/PII:0140673691907336?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

25 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

volume

337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

issue

8733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

61-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia

23 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Results and significance of six randomized trials in four consecutive ALL-BFM studies

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.

25 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X

25 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

A direct bone marrow chromosome technique for acute lymphoblastic leukemia

25 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

The cytogenetics of childhood leukemia: clinical and biologic implications

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemia

25 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Age at diagnosis in childhood acute lymphoblastic leukemia

25 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: a Pediatric Oncology Group review

25 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome.

25 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

25 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Cyclophosphamide and bone marrow transplantation

25 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity

25 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90733-6

25 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1670723 AND SRC:MED&resulttype=core&format=json

23 September 2019

1 reference